Meta Platforms
META
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
Vale SA
VALE
Tesla
TSLA
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 22.460
- -1.560-6.49%
Close Jan 10 16:00 ET
- 22.460
- 0.0000.00%
Post 16:20 ET
1.32BMarket Cap-14.97P/E (TTM)
23.760High21.600Low687.24KVolume23.290Open24.020Pre Close15.22MTurnover1.50%Turnover RatioLossP/E (Static)58.67MShares47.97052wk High7.68P/B1.03BFloat Cap20.07052wk Low--Dividend TTM45.73MShs Float318.750Historical High--Div YieldTTM8.99%Amplitude2.650Historical Low22.147Avg Price1Lot Size
Spyre Therapeutics News
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | 424B5: Prospectus
Spyre Therapeutics | 424B5: Prospectus
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-K/A: Annual report (Amendment)
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.3%),VHCP Co-Investment Holdings III, LLC(5.3%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(5.7%),Joseph Edelman(5.7%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.9%),Commodore Capital Master LP(3.9%)
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(1.97%),Deep Track Biotechnology Master Fund, Ltd.(1.97%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(1.7%),Behzad Aghazadeh(1.7%)
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Spyre Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Spyre Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Spyre Therapeutics | 8-K: Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Spyre Therapeutics | 10-Q: Q3 2024 Earnings Report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.